RCM
BIIB icon

Rotella Capital Management’s Biogen BIIB Stock Holding History

Rotella Capital Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-1,400
Closed -$429K – 35
2015
Q4 		$429K Buy
+1,400
New +$402K 0.38% 88

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Rotella Capital Management's BIIB Position: Q1 2016 in Review

Rotella Capital Management sold out of Biogen (BIIB) in Q1 2016, closing a stake of 1,400 shares — an estimated $429K sold.

Rotella Capital Management first reported a position in BIIB in Q4 2015 and held it in 1 quarter. The position peaked at $429K in Q4 2015. 948 funds tracked by Wall St. Rank hold BIIB as of Q1 2016.

  • Rotella Capital Management reported no remaining Biogen position as of Q1 2016 after selling out during the quarter.
  • Rotella Capital Management sold 1,400 Biogen shares in Q1 2016, an estimated $429K.
  • Rotella Capital Management first reported a position in Biogen in Q4 2015 and held it in 1 quarter.
  • Rotella Capital Management's Biogen position peaked at $429K in Q4 2015.
  • 948 funds tracked by Wall St. Rank held Biogen as of Q1 2016.

Based on Rotella Capital Management's 13F filing for Q1 2016, filed 13 May 2016.